TiGenix NV (TIG) - Medical Equipment - Deals and Alliances Profile
- GDME22481D
- Pages: 39
- October 2018
- Total Views:1159
- Region : Europe
- GlobalData
- Equity Research Report

Details
Summary
TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-01, AlloCSC-02, Cx611 and Cx601. TiGenix develops its products using expanded stem cells extracted from adipose tissue platform. The company's offers products with therapeutic focus on autoimmune, inflammatory and heart diseases, among others. It works in partnership with other pharmaceutical and biotechnology companies. The company has operations in Spain, the US, the Netherlands and Belgium. TiGenix is headquartered in Leuven, Belgium.
TiGenix NV (TIG)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TiGenix NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TiGenix NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TiGenix NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TiGenix NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
TiGenix NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TiGenix NV, Medical Equipment, Deal Details 10
Venture Financing 10
TiGenix Raises USD0.02 Million in Venture Financing 10
TiGenix Raises USD8.5 Million in Venture Financing 11
TiGenix Enters Licensing Agreement With Sobi for ChondroCelect 12
Equity Offering 13
TiGenix Raises USD35.7 Million in Public Offering of ADS 13
TiGenix Completes Private Placement Of Shares For USD 16.2 Million 15
TiGenix Completes Private Placement Of Shares For USD 8.5 Million 16
TiGenix Completes Private Placement Of Shares For USD 9 Million 17
Debt Offering 18
TiGenix Raises USD28.3 Million in Private Placement of 9% Bonds Due 2018 18
TiGenix Announces Private Placement Of Debt Securities For USD 13.7 Million 19
Acquisition 20
Takeda Pharma Acquires TiGenix for USD626.4 Million 20
TiGenix NV-Key Competitors 22
TiGenix NV-Key Employees 23
TiGenix NV-Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Jun 29, 2017: TiGenix opens US headquarters in Cambridge, MA 25
Financial Announcements 26
Apr 12, 2018: TiGenix reports 2017 full year results 26
Sep 19, 2017: TiGenix Business and Financial Update for the First Half 2017 30
Apr 06, 2017: TiGenix reports 2016 full year results 33
Corporate Communications 36
Jun 13, 2018: TiGenix announces Resignation Of Eduardo Bravo As Board Of Directors And CEO 36
Sep 12, 2017: TiGenix strengthens US operations with senior appointments 37
Jun 29, 2017: TiGenix opens US headquarters in Cambridge, MA 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List Of Figure
List of Figures
TiGenix NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
TiGenix NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
TiGenix NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
TiGenix NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
TiGenix NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TiGenix NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
TiGenix NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TiGenix NV, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List Of Table
List of Tables
TiGenix NV, Medical Equipment, Key Facts, 2017 2
TiGenix NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
TiGenix NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TiGenix NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TiGenix NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TiGenix NV, Deals By Market, 2012 to YTD 2018 8
TiGenix NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TiGenix Raises USD0.02 Million in Venture Financing 10
TiGenix Raises USD8.5 Million in Venture Financing 11
TiGenix Enters Licensing Agreement With Sobi for ChondroCelect 12
TiGenix Raises USD35.7 Million in Public Offering of ADS 13
TiGenix Completes Private Placement Of Shares For USD 16.2 Million 15
TiGenix Completes Private Placement Of Shares For USD 8.5 Million 16
TiGenix Completes Private Placement Of Shares For USD 9 Million 17
TiGenix Raises USD28.3 Million in Private Placement of 9% Bonds Due 2018 18
TiGenix Announces Private Placement Of Debt Securities For USD 13.7 Million 19
Takeda Pharma Acquires TiGenix for USD626.4 Million 20
TiGenix NV, Key Competitors 22
TiGenix NV, Key Employees 23
TiGenix NV, Subsidiaries 24
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
TiGenix NV, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-01, AlloCSC-02, Cx611 and Cx601. TiGenix develops its products using expanded stem cells extracted from adipose tissue platform. The company's offers products with therapeutic focus on autoimmune, inflammatory and heart diseases, among others. It works in partnership with other pharmaceutical and biotechnology companies. The company has operations in Spain, the US, the Netherlands and Belgium. TiGenix is headquartered in Leuven, Belgium.
TiGenix NV (TIG)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TiGenix NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TiGenix NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TiGenix NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TiGenix NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
TiGenix NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TiGenix NV, Medical Equipment, Deal Details 10
Venture Financing 10
TiGenix Raises USD0.02 Million in Venture Financing 10
TiGenix Raises USD8.5 Million in Venture Financing 11
TiGenix Enters Licensing Agreement With Sobi for ChondroCelect 12
Equity Offering 13
TiGenix Raises USD35.7 Million in Public Offering of ADS 13
TiGenix Completes Private Placement Of Shares For USD 16.2 Million 15
TiGenix Completes Private Placement Of Shares For USD 8.5 Million 16
TiGenix Completes Private Placement Of Shares For USD 9 Million 17
Debt Offering 18
TiGenix Raises USD28.3 Million in Private Placement of 9% Bonds Due 2018 18
TiGenix Announces Private Placement Of Debt Securities For USD 13.7 Million 19
Acquisition 20
Takeda Pharma Acquires TiGenix for USD626.4 Million 20
TiGenix NV-Key Competitors 22
TiGenix NV-Key Employees 23
TiGenix NV-Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Jun 29, 2017: TiGenix opens US headquarters in Cambridge, MA 25
Financial Announcements 26
Apr 12, 2018: TiGenix reports 2017 full year results 26
Sep 19, 2017: TiGenix Business and Financial Update for the First Half 2017 30
Apr 06, 2017: TiGenix reports 2016 full year results 33
Corporate Communications 36
Jun 13, 2018: TiGenix announces Resignation Of Eduardo Bravo As Board Of Directors And CEO 36
Sep 12, 2017: TiGenix strengthens US operations with senior appointments 37
Jun 29, 2017: TiGenix opens US headquarters in Cambridge, MA 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List Of Figure
List of Figures
TiGenix NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
TiGenix NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
TiGenix NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
TiGenix NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
TiGenix NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TiGenix NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
TiGenix NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TiGenix NV, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List Of Table
List of Tables
TiGenix NV, Medical Equipment, Key Facts, 2017 2
TiGenix NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
TiGenix NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TiGenix NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TiGenix NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TiGenix NV, Deals By Market, 2012 to YTD 2018 8
TiGenix NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TiGenix Raises USD0.02 Million in Venture Financing 10
TiGenix Raises USD8.5 Million in Venture Financing 11
TiGenix Enters Licensing Agreement With Sobi for ChondroCelect 12
TiGenix Raises USD35.7 Million in Public Offering of ADS 13
TiGenix Completes Private Placement Of Shares For USD 16.2 Million 15
TiGenix Completes Private Placement Of Shares For USD 8.5 Million 16
TiGenix Completes Private Placement Of Shares For USD 9 Million 17
TiGenix Raises USD28.3 Million in Private Placement of 9% Bonds Due 2018 18
TiGenix Announces Private Placement Of Debt Securities For USD 13.7 Million 19
Takeda Pharma Acquires TiGenix for USD626.4 Million 20
TiGenix NV, Key Competitors 22
TiGenix NV, Key Employees 23
TiGenix NV, Subsidiaries 24
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
TiGenix NV, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.